Overall rank by patents
#5,602
Across all tracked assignees
USPTO PatentsView assignee record - 61 granted patents across 36 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
Lesaffre holds 61 US patents across 36 technology areas, rank #5,602 of 50,000 tracked assignees.
Lesaffre ET Compagnie has been granted 61 US utility patents between 2015 and 2025, placing Lesaffre ET Compagnie at rank #5,602 across all assignees tracked by PlainPatent. This portfolio spans 36 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Lesaffre ET Compagnie is one of the more focused assignees in the PatentsView dataset. By volume, Lesaffre sits between Institute For Research In Biomedicine (61 patents, rank #5,598) and Maxlite, Inc (61 patents, rank #5,606) - the closest US assignees by grant volume. The composite Innovation Score of 48.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 28 grants, compared with 33 in the 2015–2019 window, a -15% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Lesaffre ET Compagnie's 13.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 36 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Lesaffre ET Compagnie against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Institute for Research in Biomedicine
61 patents
KOLSTER HOLDING B.V.
61 patents
KRAFT FOODS R & D, INC.
61 patents
Kimball International, Inc.
61 patents
LONE GULL HOLDINGS, LTD.
61 patents
Light Labs Inc.
61 patents
Lineage Logistics, LLC
61 patents
MAXLITE, INC
61 patents
LESAFFRE ET COMPAGNIE
61 patents
What this shows Lesaffre holds 61 patents at rank #5,602, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,602 in granted patent volume.
Other assignees with the most granted patents in Lesaffre's primary technology class.
Lesaffre's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 11.5% |
| 2016 | 4 | 6.6% |
| 2017 | 11 | 18.0% |
| 2018 | 4 | 6.6% |
| 2019 | 7 | 11.5% |
| 2020 | 5 | 8.2% |
| 2021 | 7 | 11.5% |
| 2022 | 3 | 4.9% |
| 2023 | 5 | 8.2% |
| 2024 | 5 | 8.2% |
| 2025 | 3 | 4.9% |
Top 15 of 36 technology areas
Overall rank by patents
#5,602
Across all tracked assignees
48.3 out of 100
How to use this portfolio
Lesaffre's 61 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.